TAXANES - A NEW CLASS OF ANTITUMOR AGENTS

被引：243
|
作者：
HUIZING, MT
MISSER, VHS
PIETERS, RC
HUININK, WWT
VEENHOF, CHN
VERMORKEN, JB
PINEDO, HM
BEIJNEN, JH
机构：
[1] SLOTERVAART HOSP,DEPT PHARM,1066 EC AMSTERDAM,NETHERLANDS
[2] NETHERLANDS CANC INST,DEPT MED ONCOL,1066 CX AMSTERDAM,NETHERLANDS
[3] UNIV AMSTERDAM,ACAD MED CTR,DEPT MED ONCOL,1105 AZ AMSTERDAM,NETHERLANDS
[4] FREE UNIV AMSTERDAM HOSP,DEPT MED ONCOL,1081 HV AMSTERDAM,NETHERLANDS
来源：
CANCER INVESTIGATION | 1995年 / 13卷 / 04期
关键词：
D O I：
10.3109/07357909509031919
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Taxanes belong to a new group of antineoplastic agents with a novel mechanism of action for a cytotoxic drug. They promote microtubule assembly and stabilize the microtubules. Paclitaxel, the first agent in this group to become available, was isolated from the Pacific yew, Taxus brevifolia, in 1971. In preclinical and clinical studies, paclitaxel and its semisynthetic analog docetaxel exhibit significant antitumor activity. This review deals with the physicochemical properties, pharmacology, and results of preclinical and clinical trials of the taxanes.
引用
收藏
页码：381 / 404
页数：24
相关论文
共 50 条
  • [41] Preclinical antitumor activity of two novel taxanes
    William C. Rose
    Craig Fairchild
    Francis Y.F. Lee
    Cancer Chemotherapy and Pharmacology, 2001, 47 : 97 - 105
  • [42] Proteasome inhibitors: A novel class of potent and effective antitumor agents
    Adams, J
    Palombella, VJ
    Sausville, EA
    Johnson, J
    Destree, A
    Lazarus, DD
    Maas, J
    Pien, CS
    Prakash, S
    Elliott, PJ
    CANCER RESEARCH, 1999, 59 (11) : 2615 - 2622
  • [43] SYNTHESIS OF THE BICYCLIC CORE OF THE ESPERAMICIN CALICHEMICIN CLASS OF ANTITUMOR AGENTS
    SCHREIBER, SL
    KIESSLING, LL
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1988, 110 (02) : 631 - 633
  • [44] REDOX CHEMISTRY OF THE 9-ANILINOACRIDINE CLASS OF ANTITUMOR AGENTS
    JURLINA, JL
    LINDSAY, A
    PACKER, JE
    BAGULEY, BC
    DENNY, WA
    JOURNAL OF MEDICINAL CHEMISTRY, 1987, 30 (03) : 473 - 480
  • [45] Benzo[b]acronycine derivatives:: a novel class of antitumor agents
    Michel, S
    Gaslonde, T
    Tillequin, F
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2004, 39 (08) : 649 - 655
  • [46] Using celecoxib as a molecular platform for developing a new class of Akt-targeted antitumor agents.
    Zhu, JX
    Huang, JW
    Fowble, J
    Kulp, SK
    Chen, CS
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 227 : U11 - U11
  • [47] Ras farnesyltransferase inhibitors as a new class of antitumor agents: A chemical approach to controlling cell signaling.
    Qian, YM
    Vogt, A
    Sebti, SM
    Hamilton, AD
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1996, 211 : 12 - COMP
  • [48] Quinazoline-tyrphostin as a new class of antitumor agents, molecular properties prediction, synthesis and biological testing
    Alafeefy, Ahmed M.
    Alqasoumi, Saleh I.
    Ashour, Abdelkader E.
    Masand, Vijay
    Al-Jaber, Nabila A.
    Ben Hadda, Taibi
    Mohamed, Menshawy A.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2012, 53 : 133 - 140
  • [49] Antimitochondrial agents:: a new class of anticancer agents
    André, N
    Rome, A
    Carré, M
    ARCHIVES DE PEDIATRIE, 2006, 13 (01): : 69 - 75
  • [50] New antitumor agents: Structure and synthesis studies
    Hoye, TR
    Ayyad, SEN
    Judd, AS
    Shier, WT
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1998, 216 : U363 - U363
12345